tallózása szerző szerint "Shariat SF"

A találatok rendezése: Rendezés: Találatok:

  • A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22 393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients 
    Sooriakumaran P; Srivastava A; Shariat SF; Stricker PD; Ahlering T; Eden CG; Wiklund PN; Sanchez-Salas R; Mottrie A; Lee D; Neal DE; Ghavamian R; Nyirády, Péter; Nilsson A; Carlsson S; Xylinas E; Loidl W; Seitz C; Schramek P; Roehrborn C; Cathelineau X; Skarecky D; Shaw G; Warren A; Delprado WJ; Haynes A-M; Steyerberg E; Roobol MJ; Tewari AK (2014)
    Background: Positive surgical margins (PSMs) are a known risk factor for biochemical recurrence in patients with prostate cancer (PCa) and are potentially affected by surgical technique and volume. Objective: To investigate ...
  • Circulating and tissue expression levels of YKL-40 in renal cell cancer 
    Vom Dorp F; Tschirdewahn S; Niedworok C; Reis H; Krause H; Kempkensteffen C; Busch J; Kramer G; Shariat SF; Nyirády, Péter; Rubben H; Szarvas, Tibor (2016)
    PURPOSE: Blood levels of YKL-40 are elevated in various malignancies and other inflammatory diseases. Moreover, higher YKL-40 levels, have consequently been shown to correlate with poor prognosis in several cancers. The ...
  • Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer. 
    Szarvas, Tibor; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky, Ilona; Rubben H (2014)
    In this study, we assessed the changes and prognostic relevance of syndecan-1 (SDC1) tissue and serum levels in bladder cancer (BC). SDC1 levels were analyzed in 213 samples (119 paraffin-embedded and 79 serum samples of ...
  • Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma - occurence and prognostic significance 
    Módos, Orsolya; Reis H; Niedworok C; Rubben H; Szendrői, Attila; Szász, Attila; Tímár, József; Baghy K; Kovalszky I; Golabek T; Chlosta P; Okon K; Peyronnet B; Mathieu R; Shariat SF; Hollosi P; Nyirády, Péter; Szarvas, Tibor (2016)
    PURPOSE: Targeted therapy represents an attractive alternative for rare tumors such as urachal carcinoma (UrC). The aim of this study was to assess the mutations of the most commonly affected 5 genes in the targetable ...
  • Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. 
    Tschirdewahn S; Reis H; Niedworok C; Nyirády Péter; Szendrői Attila; Schmid KW; Shariat SF; Kramer G; Vom Dorp F; Rubben H; Szarvas T (2014)
    OBJECTIVES: YKL-40 is a novel inflammatory serum protein shown to be associated with the presence and prognosis of several malignancies. However, its prognostic relevance has not yet been analyzed in bladder cancer (BC). ...